← Eichor
Study identifier: NCT07214779 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Condition: Ovarian Cancer  ·  Sponsor: Incyte Corporation

PhasePhase 3
Planned participants466
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to evaluate INCB123667 versus investigator's choice of chemotherapy in participants with platinum-resistant ovarian cancer with cyclin E1 overexpression.

This description comes directly from the study's public registry record.

Talk to the study team

Incyte Corporation Call Center (US)  ·  1.855.463.3463  ·  medinfo@incyte.com

Incyte Corporation Call Center (ex-US)  ·  +800 00027423  ·  eumedinfo@incyte.com

Always discuss trial participation with your own doctor first.

Locations (178)

Alaska Womens Cancer Care AkwccAnchorage, Alaska, United StatesNot Yet Recruiting
University of Arizona Cancer CenterTucson, Arizona, United StatesNot Yet Recruiting
City of Hope Medical CenterDuarte, California, United StatesNot Yet Recruiting
Providence Medical FoundationFullerton, California, United StatesNot Yet Recruiting
University of California, San Diego-Moores Cancer CenterLa Jolla, California, United StatesNot Yet Recruiting
Valkyrie Clinical TrialsLos Angeles, California, United StatesRecruiting
Chao Family Comprehensive Cancer Center University of California, IrvineOrange, California, United StatesNot Yet Recruiting
Ventura County Hematology Oncology Specialists-OxnardOxnard, California, United StatesNot Yet Recruiting
University of Colorado Cancer CenterAurora, Colorado, United StatesNot Yet Recruiting
Brcr GlobalMiramar, Florida, United StatesNot Yet Recruiting
Winship Cancer Institute At Emory UniversityAtlanta, Georgia, United StatesNot Yet Recruiting
Georgia Cancer CenterAugusta, Georgia, United StatesNot Yet Recruiting

+ 166 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07214779